Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.36 |
| ▸ | GABRD | O14764 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.36 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.36 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.36 |
| ▸ | GABRE | P78334 | 1/20 | 0.36 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.36 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.36 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.36 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.36 |
| ▸ | NQO1 | P15559 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7592261 | 0.87 | MAPT (0.48) | MAPTGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL7935485 | 0.82 | GABRP (0.39) | MAPTGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL9071112 | 0.81 | NCF1 (0.34) | MAPTPOLBHTTLMNAKDM4E | |
| SCHEMBL12301435 | 0.80 | MAPT (0.44) | MAPTGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL15483093 | 0.79 | BACE1 (0.35) | POLBRXRAGRIN1GRIN2B | |
| SCHEMBL18480437 | 0.77 | CDK1 (0.35) | RXRAGRIN1GRIN2B | |
| SCHEMBL12445699 | 0.76 | KDM4E (0.35) | MAPTPOLBRXRAGRIN1GRIN2B | |
| SCHEMBL20176279 | 0.76 | TAAR1 (0.34) | POLBSMN1; SMN2RXRAGRIN1GRIN2B | |
| SCHEMBL7935597 | 0.76 | APP (0.35) | MAPTPOLBRXRAGRIN1GRIN2B | |
| SCHEMBL31445673 | 0.76 | TAAR1 (0.34) | POLBSMN1; SMN2RXRAGRIN1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119549075-A | Perfume microcapsule for heating non-combustible cigarettes and preparation method and application thereof | 山东中烟工业有限责任公司 | 2025-03-04 | — | — | CN | claimed |
| US-20220370615-A1 | Prevention of Illicit Manufacture of Methamphetamine from Pseudoephedrine Using Food Flavor Excipients | Satara Pharmaceuticals (US) | 2022-11-24 | — | — | US | claimed |
| US-20200289552-A1 | SOLID COMPOSITION COMPRISING IODINE AGENT AND SODIUM CHLORIDE HAVING IMPROVED WATER SOLUBILITY, AND ANTIVIRAL AND ANTIMICROBIAL COMPOSITION FOR EYE, ORAL CAVITY, NASAL CAVITY OR INHALATION CONTAINING AQUEOUS SOLUTION THEREOF | FLUCHEM LTD (KR) | 2020-09-17 | — | — | US | claimed |
| EP-3650012-A1 | SOLID COMPOSITION COMPRISING IODINE AGENT AND SODIUM CHLORIDE HAVING IMPROVED WATER SOLUBILITY, AND ANTIVIRAL AND ANTIMICROBIAL COMPOSITION FOR EYE, ORAL CAVITY, NASAL CAVITY OR INHALATION CONTAINING AQUEOUS SOLUTION THEREOF | Fluchem Ltd (KR) | 2020-05-13 | — | — | EP | claimed |
| CN-110799179-A | Solid composition comprising iodine reagent and sodium chloride with improved water solubility and antiviral and antibacterial composition for eye, oral cavity, nasal cavity or inhalation comprising aqueous solution thereof | 富陆凯米有限责任公司 | 2020-02-14 | — | — | CN | claimed |
| US-20160089439-A1 | Prevention of Illicit Manufacutre of Methamphetamine from Pseudoephedrine Using Food Flavor Excipients | Satara Pharmaceuticals, LLC (US) | 2016-03-31 | — | — | US | claimed |
| WO-2015048597-A1 | PREVENTION OF ILLICIT METHAMPHETAMINE MANUFACTURE FROM PSEUDOEPHEDRINE USING FOOD FLAVOR EXCIPIENTS | Daya Drug Discoveries, Inc. (US) | 2015-04-02 | — | — | WO | claimed |
| WO-2025047604-A1 | ANIMAL OIL/FAT FLAVOR-IMPARTING AGENT | 味の素株式会社 | 2025-03-06 | — | — | WO | disclosed |
| US-11771738-B2 | Endoparasitic depsipeptides | ZOETIS SERVICES LLC (US) | 2023-10-03 | — | — | US | disclosed |
| US-11771738-B2 | Endoparasitic depsipeptides | ZOETIS SERVICES LLC (US) | 2023-10-03 | — | — | US | disclosed |
| EP-3555080-B1 | OXAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE | AMGEN INC (US) | 2023-09-20 | — | — | EP | disclosed |
| US-11697646-B2 | Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-07-11 | — | — | US | disclosed |
| EP-4205565-A1 | TOBACCO FILLING MATERIAL AND TOBACCO PRODUCT | Japan Tobacco Inc. (JP) | 2023-07-05 | — | — | EP | disclosed |
| US-8207337-B2 | Reagent for organic synthesis reaction containing organic triol borate salt | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-26 | — | — | US | disclosed |
| US-8207337-B2 | Reagent for organic synthesis reaction containing organic triol borate salt | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-26 | — | — | US | disclosed |
| US-20110237576-A1 | 2-AMINOPYRIMIDIN-4-ONE AND 2-AMINOPYRIDINE DERIVATIVES BOTH HAVING BACE1-INHIBITING ACTIVITY | SHIONOGI & CO., LTD. (JP) | 2011-09-29 | — | — | US | disclosed |
| WO-2010047372-A1 | 2-AMINOPYRIDIN-4-ONE AND 2-AMINOPYRIDINE DERIVATIVE BOTH HAVING BACE1-INHIBITING ACTIVITY | 塩野義製薬株式会社 (JP) | 2010-04-29 | — | — | WO | disclosed |
| US-20100087646-A1 | REAGENT FOR ORGANIC SYNTHESIS REACTION CONTAINING ORGANIC TRIOL BORATE SALT | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-08 | — | — | US | disclosed |
| US-20100087646-A1 | REAGENT FOR ORGANIC SYNTHESIS REACTION CONTAINING ORGANIC TRIOL BORATE SALT | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-08 | — | — | US | disclosed |
| WO-2009133687-A1 | CYCLOPENTYLACRYLIC ACID AMIDE DERIVATIVE | 杏林製薬株式会社 (JP) | 2009-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220370615-A1 | Prevention of Illicit Manufacture of Methamphetamine from Pseudoephedrine Using Food Flavor Excipients | MCHR1, TAAR5, COMT | MAPT 37/4885GABRP 1775/4885GABRD 1448/4885 |
| US-11771738-B2 | Endoparasitic depsipeptides | VIP, PREP, VIPR1 | MAPT 4773/4885GABRP 3417/4885GABRD 4532/4885 |
| US-20110237576-A1 | 2-AMINOPYRIMIDIN-4-ONE AND 2-AMINOPYRIDINE DERIVATIVES BOTH HAVING BACE1-INHIBITING ACTIVITY | BACE1, APP, BACE2 | MAPT 38/4885GABRP 1399/4885GABRD 2843/4885 |
| US-20160089439-A1 | Prevention of Illicit Manufacutre of Methamphetamine from Pseudoephedrine Using Food Flavor Excipients | PNMT, ACHE, COMT | MAPT 96/4885GABRP 2420/4885GABRD 2108/4885 |
| US-20100087646-A1 | REAGENT FOR ORGANIC SYNTHESIS REACTION CONTAINING ORGANIC TRIOL BORATE SALT | ORC3, OXSR1, OSTC | MAPT 3317/4885GABRP 2838/4885GABRD 4100/4885 |
| US-11697646-B2 | Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists | LPAR3, LPAR1, LPAR2 | MAPT 932/4885GABRP 1179/4885GABRD 2327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.